tuesdays at dawn

the add-back that won't die.

four years after PPP loans expired, COVID-era EBITDA add-backs are still showing up in CIMs. we've seen three this month alone.

on a $5M EBITDA business at 6.8x, a $300K add-back inflates the purchase price by over $2 million. that's the game.

the pitch is always the same: "one-time, non-recurring." but when you've been saying that since 2021, it stops being one-time. it's a pattern. and every buyer who doesn't catch it is overpaying — not by a little, by a multiple of the add-back itself.

here's what we're seeing:

none of this is illegal. most of it isn't even unusual. but that's what makes it dangerous — it's normalized. bankers include it because sellers expect it. buyers accept it because the model already has it baked in. and the deal closes at a price that doesn't reflect the actual cash flow of the business.

the fix isn't complicated. run the model without the add-backs. if the deal still works, fine. if it doesn't — that tells you something.

— the editors


← back to issues